Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 108.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 81
  • Market Cap: 115.76m
  • RiskGrade: 187

Current

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 130.06 13.70 9.42p 11.5 n/a -1% 2.62p 2.4%
31-Dec-21 135.58 14.20 9.93p 10.9 2.0 +5% 4.33p 4.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2020 130 n/a n/a n/a n/a n/a
31-Dec-2021 136 n/a n/a n/a n/a n/a
 
Earnings
31-Dec-2020 9.42p n/a n/a n/a n/a n/a
31-Dec-2021 9.93p n/a n/a n/a n/a n/a
 
Dividend
31-Dec-2020 2.62p n/a n/a n/a n/a n/a
31-Dec-2021 4.33p n/a n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 1 0 0 0 0 0
 
Average Rec 5.00 n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 108.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 101.00
Volume 81
Shares Issued 106.69m
Market Cap 115.76m
RiskGrade 187

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.83% below the market average38.83% below the market average38.83% below the market average38.83% below the market average38.83% below the market average
83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average83.33% above the sector average
Price Trend
3.85% below the market average3.85% below the market average3.85% below the market average3.85% below the market average3.85% below the market average
43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average43.59% below the sector average
Income
11.85% above the market average11.85% above the market average11.85% above the market average11.85% above the market average11.85% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.6% below the market average37.6% below the market average37.6% below the market average37.6% below the market average37.6% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 01-Jun-2020

Time Volume / Share Price
09:50 81 @ 110.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page